ALSO NOTED: Clinphone shares rise on debut; Allergan gets FDA OK for eye drug; and much more...

> Shares of Clinphone, a UK company that assists researchers in managing clinical trials, saw its shares jump 15 percent on its market debut. Report

> The FDA has approved Allergan's once daily Lumigan as a first-line therapy for elevated intraocular pressure. Report

> Shares of Altus Pharmaceuticals were buoyed by positive Phase II data for its once-weekly form of a human growth hormone--ALTU-238. Report

> Pharmaceutical benefit managers and other drug buyers are exacting bigger and bigger discounts for preferred drugs, as drug makers see their position at the bargaining table weakened. Article (WSJ sub. req.)

> Pliva may soon announce the winner in a $2 billion bidding war for the Croatian drug maker. Report

> Scios is laying off 350 workers in Fremont, CA as part of a company realignment. Report

> Sandoz has filed a complaint in court asking that Teva's version of Zocor be delayed until the FDA approves its own copycat drug. Report

And Finally… Illegal tattoos are helping spread a deadly, drug resistant infection. Article